---
title: "Pasithea Therapeutics Appoints Kartik Krishnan As CMO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285065041.md"
description: "Pasithea Therapeutics Corporation (KTTA) has appointed Kartik Krishnan as chief medical officer effective May 1. Krishnan brings over 20 years of experience in clinical development and related fields, previously serving as CEO at OncoNano Medicines, a company focused on anti-cancer assets."
datetime: "2026-05-04T11:37:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285065041.md)
  - [en](https://longbridge.com/en/news/285065041.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285065041.md)
---

# Pasithea Therapeutics Appoints Kartik Krishnan As CMO

Add  as your preferred news source on Google

 Add Now

Pasithea Therapeutics Corporation (KTTA) said on Monday that it has appointed Kartik Krishnan as chief medical officer with effect from May 1.

Krishnan has over 20 years of experience in clinical development, pharmacovigilance, clinical operations, and others.

Prior to joining Pasithea, Krishnan was chief executive officer at OncoNano Medicines, a privately held company developing anti-cancer assets.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [KTTAW.US](https://longbridge.com/en/quote/KTTAW.US.md)
- [KTTA.US](https://longbridge.com/en/quote/KTTA.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)